Key result
Dichloroacetate treatment significantly improved the right ventricular contractile reserve during dobutamine stress (15 vs 1.4 percent points, P<0.001) and prevented myocardial hypertrophy.
Why the study?
In heart failure, myocardial overload impairs cardiac energy production and worsens contractile function, but metabolic therapy is not used in clinical care.
Does dichloroacetate improve contractile reserves and prevent hypertrophy in a porcine model of right heart failure?
Does dichloroacetate improve contractile reserves and prevent hypertrophy in a porcine model of right heart failure?
In a porcine model of right heart failure, increasing carbohydrate oxidation with dichloroacetate improved contractile reserve and prevented myocardial hypertrophy, suggesting a potential metabolic therapy for heart failure.
No immediate clinical implications; leaves open dichloroacetate for right ventricular metabolic modulation pending human trials.
In heart failure, myocardial overload causes vast metabolic changes that impair cardiac energy production and contribute to deterioration of contractile function. However, metabolic therapy is not used in heart failure care. We aimed to investigate the interplay between cardiac function and myocardial carbohydrate metabolism in a large animal heart failure model. Using magnetic resonance spectroscopy with hyperpolarized pyruvate and magnetic resonance imaging at rest and during pharmacological stress, we investigated the in-vivo cardiac pyruvate metabolism and contractility in a porcine model of chronic pulmonary insufficiency causing right ventricular volume overload. To assess if increasing the carbohydrate metabolic reserve improves the contractile reserve, a group of animals were fed dichloroacetate, an activator of pyruvate oxidation. Volume overload caused heart failure with decreased pyruvate dehydrogenase flux and poor ejection fraction reserve. The animals treated with dichloroacetate had a larger contractile response to dobutamine stress than non-treated animals. Further, dichloroacetate prevented myocardial hypertrophy. The in-vivo metabolic data were validated by mitochondrial respirometry, enzyme activity assays and gene expression analyses. Our results show that pyruvate dehydrogenase kinase inhibition improves the contractile reserve and decreases hypertrophy by augmenting carbohydrate metabolism in porcine heart failure. The approach is promising for metabolic heart failure therapy.
No takes yet. Share an insight, caveat, or question.
Bøgh et al. (2020) studied Right ventricular volume overload (Right heart failure) (n=15). Dichloroacetate (DCA) vs. No treatment was evaluated on Right ventricular contractile reserve (increase in ejection fraction from rest to dobutamine stress) (p=<0.001). Dichloroacetate treatment significantly improved the right ventricular contractile reserve during dobutamine stress (15 vs 1.4 percent points, P<0.001) and prevented myocardial hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: